SCHEMBL453503

SCHEMBL453503

O=S(=O)(NCCO)c1cc(Nc2c(Cl)cc(Cl)cc2Cl)ccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 7/20 0.63
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
PIK3CD O00329 3/20 0.42
PIK3CG P48736 3/20 0.42
PI4KB Q9UBF8 2/20 0.42
PIK3C2A O00443 1/20 0.42
PIK3C2B O00750 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PI4KA P42356 1/20 0.42
PRKDC P78527 1/20 0.42
PIK3C3 Q8NEB9 1/20 0.42
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
CCR1 P32246 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449608 0.88 GSTO1 (0.58) GSTO1GAAMAPTTHRBPIK3CD
SCHEMBL439443 0.81 CYP2C19 (0.51) GSTO1GAA
SCHEMBL3717918 0.80 GAA (0.67) GSTO1GAAMAPTPIK3CDPIK3CG
SCHEMBL30794423 0.79 GSTO1 (0.44) GSTO1GAAMAPTTHRBPDK1
SCHEMBL439442 0.79 GSTO1 (0.44) GSTO1GAAMAPTTHRBPDK1
SCHEMBL9321470 0.75 GSTO1 (0.60) GSTO1GAATHRBPIK3CDPIK3CG
SCHEMBL9321467 0.75 GSTO1 (0.60) GSTO1GAAPIK3CDPIK3CGPI4KB
SCHEMBL30516775 0.75 GSTO1 (0.60) GSTO1GAATHRBPIK3CDPIK3CG
SCHEMBL438018 0.74 TOP2A (0.38) GSTO1
SCHEMBL448977 0.71 CYP2C19 (0.46) GSTO1GAAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231594-B1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF UNIV RAMOT (IL) 2013-03-27 EP claimed
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2012-03-15 US claimed
EP-2231594-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF Ramot at Tel-Aviv University Ltd (IL) 2010-09-29 EP claimed
WO-2009071947-A2 POTASSIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2009-06-11 WO claimed
US-8466201-B2 Potassium ion channel modulators and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2013-06-18 US disclosed
EP-2231594-B1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF UNIV RAMOT (IL) 2013-03-27 EP disclosed
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2012-03-15 US disclosed
EP-2231594-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF Ramot at Tel-Aviv University Ltd (IL) 2010-09-29 EP disclosed
WO-2009071947-A2 POTASSIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065270-A1 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF KCNN3, SCN2B, SCN1B GSTO1 1842/4885GAA 4818/4885MAPT 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.